Detailed information for compound 109401

Basic information

Technical information
  • TDR Targets ID: 109401
  • Name: [(1R,2R)-2-[(4-hydroxybenzoyl)amino]cyclopent yl] 3,5-dihydroxy-4-(2-hydroxy-6-methoxycarbo nylbenzoyl)benzoate
  • MW: 535.499 | Formula: C28H25NO10
  • H donors: 5 H acceptors: 8 LogP: 4.05 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 2
  • SMILES: COC(=O)c1cccc(c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1NC(=O)c1ccc(cc1)O)O
  • InChi: 1S/C28H25NO10/c1-38-28(37)17-4-2-6-19(31)23(17)25(34)24-20(32)12-15(13-21(24)33)27(36)39-22-7-3-5-18(22)29-26(35)14-8-10-16(30)11-9-14/h2,4,6,8-13,18,22,30-33H,3,5,7H2,1H3,(H,29,35)/t18-,22-/m1/s1
  • InChiKey: JOOTZGPUMCZHLH-XMSQKQJNSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • [(1R,2R)-2-[(4-hydroxybenzoyl)amino]cyclopentyl] 3,5-dihydroxy-4-(2-hydroxy-6-methoxycarbonyl-benzoyl)benzoate
  • 3,5-dihydroxy-4-[(2-hydroxy-6-methoxycarbonylphenyl)-oxomethyl]benzoic acid [(1R,2R)-2-[[(4-hydroxyphenyl)-oxomethyl]amino]cyclopentyl] ester
  • [(1R,2R)-2-[(4-hydroxyphenyl)carbonylamino]cyclopentyl] 3,5-dihydroxy-4-(2-hydroxy-6-methoxycarbonyl-phenyl)carbonyl-benzoate
  • 4-(2-carbomethoxy-6-hydroxy-benzoyl)-3,5-dihydroxy-benzoic acid [(1R,2R)-2-[(4-hydroxybenzoyl)amino]cyclopentyl] ester

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens protein kinase C, alpha Starlite/ChEMBL No references
Homo sapiens protein kinase C, eta Starlite/ChEMBL No references
Homo sapiens protein kinase C, beta Starlite/ChEMBL No references
Homo sapiens protein kinase C, delta Starlite/ChEMBL No references
Homo sapiens protein kinase C, epsilon Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus Protein kinase C brain isozyme Get druggable targets OG5_129482 All targets in OG5_129482
Entamoeba histolytica PH domain containing protein kinase, putative Get druggable targets OG5_129314 All targets in OG5_129314
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_129314 All targets in OG5_129314
Echinococcus multilocularis Protein kinase C, brain isozyme Get druggable targets OG5_129482 All targets in OG5_129482
Brugia malayi protein kinase C II. Get druggable targets OG5_129314 All targets in OG5_129314
Loa Loa (eye worm) AGC/PKC/ALPHA protein kinase Get druggable targets OG5_129482 All targets in OG5_129482
Echinococcus multilocularis serine threonine protein kinase Get druggable targets OG5_129482 All targets in OG5_129482
Schistosoma japonicum Calcium-dependent protein kinase C, putative Get druggable targets OG5_129482 All targets in OG5_129482
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_129482 All targets in OG5_129482
Candida albicans protein kinase C similar to S. cerevisiae PKC1 (YBL105C) Get druggable targets OG5_129482 All targets in OG5_129482
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Schistosoma japonicum Protein kinase C epsilon type, putative Get druggable targets OG5_129314 All targets in OG5_129314
Echinococcus granulosus serine:threonine protein kinase N2 Get druggable targets OG5_129314 All targets in OG5_129314
Onchocerca volvulus Get druggable targets OG5_132502 All targets in OG5_132502
Echinococcus granulosus protein kinase c epsilon type Get druggable targets OG5_129314 All targets in OG5_129314
Candida albicans protein kinase C similar to S. cerevisiae PKC1 (YBL105C) Get druggable targets OG5_129482 All targets in OG5_129482
Echinococcus multilocularis telomerase reverse transcriptase subunit Get druggable targets OG5_129482 All targets in OG5_129482
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Schistosoma japonicum IPR000477,RNA-directed DNA polymerase (Reverse transcriptase),domain-containing Get druggable targets OG5_129482 All targets in OG5_129482
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_129482 All targets in OG5_129482
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132502 All targets in OG5_132502
Echinococcus multilocularis RNA directed DNA polymerase Get druggable targets OG5_129482 All targets in OG5_129482
Echinococcus multilocularis serine:threonine protein kinase N2 Get druggable targets OG5_129314 All targets in OG5_129314
Schistosoma japonicum Protein kinase C alpha type, putative Get druggable targets OG5_129482 All targets in OG5_129482
Echinococcus granulosus protein kinase C gamma type Get druggable targets OG5_129482 All targets in OG5_129482
Brugia malayi Protein kinase c protein 2 Get druggable targets OG5_129482 All targets in OG5_129482
Loa Loa (eye worm) AGC/PKC/ETA protein kinase Get druggable targets OG5_129314 All targets in OG5_129314
Schistosoma japonicum ko:K06068 novel protein kinase C, putative Get druggable targets OG5_129314 All targets in OG5_129314
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_129482 All targets in OG5_129482
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_129482 All targets in OG5_129482
Echinococcus multilocularis protein kinase c epsilon type Get druggable targets OG5_129314 All targets in OG5_129314
Schistosoma japonicum Protein kinase C gamma type, putative Get druggable targets OG5_129482 All targets in OG5_129482
Schistosoma japonicum Protein kinase C alpha type, putative Get druggable targets OG5_129482 All targets in OG5_129482
Echinococcus granulosus RNA directed DNA polymerase Get druggable targets OG5_129482 All targets in OG5_129482

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis AGC family protein kinase 0.0054 0 0.5
Echinococcus multilocularis Protein kinase C, brain isozyme 0.0194 0.6616 0.6616
Trichomonas vaginalis AGC family protein kinase 0.0054 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0167 0.5329 0.5329
Trypanosoma brucei rac serine-threonine kinase, putative 0.0054 0 0.5
Trichomonas vaginalis AGC family protein kinase 0.0054 0 0.5
Echinococcus multilocularis serine:threonine protein kinase N2 0.0221 0.7897 0.7897
Echinococcus granulosus serine:threonine protein kinase N2 0.0168 0.5384 0.5384
Echinococcus multilocularis protein kinase c epsilon type 0.0265 1 1
Echinococcus granulosus protein kinase C gamma type 0.0156 0.48 0.48
Schistosoma mansoni serine/threonine protein kinase 0.0194 0.6616 0.6616
Schistosoma mansoni atypical protein kinase C 0.0093 0.1816 0.1816
Echinococcus multilocularis RNA directed DNA polymerase 0.0095 0.1944 0.1944
Echinococcus multilocularis telomerase reverse transcriptase subunit 0.0095 0.1944 0.1944
Schistosoma mansoni serine/threonine protein kinase 0.0265 1 1
Echinococcus granulosus protein kinase c epsilon type 0.0265 1 1
Loa Loa (eye worm) hypothetical protein 0.0167 0.5329 0.5329
Trichomonas vaginalis AGC family protein kinase 0.0054 0 0.5
Trichomonas vaginalis AGC family protein kinase 0.0054 0 0.5
Echinococcus granulosus RNA directed DNA polymerase 0.0095 0.1944 0.1944
Schistosoma mansoni serine/threonine protein kinase 0.0194 0.6616 0.6616
Trichomonas vaginalis AGC family protein kinase 0.0054 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0134 0.376 0.376
Brugia malayi Protein kinase c protein 2 0.0141 0.4103 0.4103
Loa Loa (eye worm) hypothetical protein 0.0095 0.1944 0.1944
Loa Loa (eye worm) hypothetical protein 0.0167 0.5329 0.5329
Echinococcus granulosus Protein kinase C brain isozyme 0.0194 0.6616 0.6616
Toxoplasma gondii AGC kinase 0.0054 0 0.5
Echinococcus multilocularis serine threonine protein kinase 0.0156 0.48 0.48
Onchocerca volvulus 0.0167 0.5329 0.5
Loa Loa (eye worm) AGC/PKC/ALPHA protein kinase 0.0102 0.2287 0.2287
Trichomonas vaginalis AGC family protein kinase 0.0054 0 0.5
Trichomonas vaginalis AGC family protein kinase 0.0054 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0221 0.7897 0.7897
Loa Loa (eye worm) AGC/PKC/ETA protein kinase 0.0265 1 1
Trichomonas vaginalis AGC family protein kinase 0.0054 0 0.5
Trichomonas vaginalis AGC family protein kinase 0.0054 0 0.5
Trichomonas vaginalis AGC family protein kinase 0.0054 0 0.5
Echinococcus multilocularis protein kinase c iota type 0.0093 0.1816 0.1816
Loa Loa (eye worm) hypothetical protein 0.0205 0.7145 0.7145
Entamoeba histolytica PH domain containing protein kinase, putative 0.0168 0.5384 1
Echinococcus granulosus protein kinase c iota type 0.0093 0.1816 0.1816

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.004 uM Inhibition of Protein kinase C eta expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.004 uM Inhibition of Protein kinase C eta expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.005 uM Inhibition of Protein kinase C delta expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.005 uM Inhibition of Protein kinase C delta expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.03 uM Inhibition of Protein kinase C delta expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.03 uM Inhibition of Protein kinase C eta expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.03 uM Inhibition of Protein kinase C delta expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.03 uM Inhibition of Protein kinase C eta expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.04 uM Inhibition of Protein kinase C beta 2 expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.04 uM Inhibition of Protein kinase C beta 2 expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.21 uM Inhibition of Protein kinase C alpha expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.21 uM Inhibition of Protein kinase C alpha expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.25 uM Inhibition of Protein kinase C delta expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.25 uM Inhibition of Protein kinase C delta expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.26 uM Inhibition of protein kinase C epsilon expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.26 uM Inhibition of protein kinase C epsilon expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.3 uM Inhibition of protein kinase C epsilon expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.3 uM Inhibition of protein kinase C epsilon expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.32 uM Inhibition of Protein kinase C alpha expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.32 uM Inhibition of Protein kinase C alpha expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.33 uM Inhibition of Protein kinase C beta 2 expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.33 uM Inhibition of Protein kinase C beta 2 expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.4 uM Inhibition of Protein kinase C eta expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 0.4 uM Inhibition of Protein kinase C eta expressed in Sf-9 cells ChEMBL. No reference
IC50 (functional) > 0.8 uM Compound was tested for inhibition of phorbol-induced superoxide generation in human neutrophils using neutrophil assay; value ranges from 0.8-2.1 ChEMBL. No reference
IC50 (functional) > 0.8 uM Compound was tested for inhibition of phorbol-induced superoxide generation in human neutrophils using neutrophil assay; value ranges from 0.8-2.1 ChEMBL. No reference
IC50 (functional) > 1.5 uM Compound was tested for inhibition of phorbol-induced superoxide generation in human neutrophils using neutrophil assay ChEMBL. No reference
IC50 (functional) > 1.5 uM Compound was tested for inhibition of phorbol-induced superoxide generation in human neutrophils using neutrophil assay ChEMBL. No reference
IC50 (functional) > 1.72 uM Compound was tested for inhibition of phorbol-induced superoxide generation in human neutrophils after 1 hr preincubation at 4 degree C using neutrophil assay; value ranges from 1.72-3.92 ChEMBL. No reference
IC50 (functional) > 1.72 uM Compound was tested for inhibition of phorbol-induced superoxide generation in human neutrophils after 1 hr preincubation at 4 degree C using neutrophil assay; value ranges from 1.72-3.92 ChEMBL. No reference
IC50 (binding) = 1.8 uM Inhibition of Protein kinase C beta 2 expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 1.8 uM Inhibition of Protein kinase C beta 2 expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 4.2 uM Inhibition of Protein kinase C alpha expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 4.2 uM Inhibition of Protein kinase C alpha expressed in Sf-9 cells ChEMBL. No reference
IC50 (functional) > 10 uM Compound was tested for inhibition of phorbol-induced superoxide generation in human neutrophils using neutrophil assay ChEMBL. No reference
IC50 (functional) > 10 uM Compound was tested for inhibition of phorbol-induced superoxide generation in human neutrophils using neutrophil assay ChEMBL. No reference
IC50 (binding) = 20 uM Inhibition of protein kinase C epsilon expressed in Sf-9 cells ChEMBL. No reference
IC50 (binding) = 20 uM Inhibition of protein kinase C epsilon expressed in Sf-9 cells ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.